MORC2 and neoplasm: The experiment indicated that depletion of MORC2 significantly reduced the number of metastatic tumours in the lungs in vivo as compared with shNC control, and 17‐AAG more effectively reduced lung metastatic potential in mice bearing shNC tumours than in those injected with shMORC2 cells (Figure 6F,G).